¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦108Â÷ ´ëÇÑ»êºÎÀΰúÇÐȸ Çмú´ëȸ(1ÀÏÂ÷) : 2022-11-11

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
Á¦108Â÷ ´ëÇÑ»êºÎÀΰúÇÐȸ Çмú´ëȸ(1ÀÏÂ÷) : 2022-11-11
±³À°ÀÏÀÚ : 2022-11-11
±³À°Àå¼Ò : ¼Ûµµ ÄÁº¥½Ã¾Æ  
±³À°ÁÖÁ¦ : (¿ÀÇÁ¶óÀÎ) Á¦108Â÷ ´ëÇÑ»êºÎÀΰúÇÐȸ Çмú´ëȸ(1ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇÑ»êºÎÀΰúÇÐȸ
´ã´çÀÚ : À¯´ÙÀÎ
¿¬¶ôó : 02-3445-2262  
À̸ÞÀÏ : office@ksog.org      
±³À°Á¾·ù : »êºÎÀΰúÀÇ·áÁ¤Ã¥
Âü¼®¿¹»óÀοø : 1800¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ÀÎõ±¤¿ª½Ã
±³À°½Ã°£ : 31 ½Ã°£ 38ºÐ  
¼¼ºÎ¼ö°­·á : 150,000¿ø      
ºñ°í Àü°øÀÇ 90,000¿ø, Àü¹®ÀÇ 120,000¿ø, ºñȸ¿ø(¿¬±¸¿ø,°£È£»ç) 100,000¿ø, ºñȸ¿ø 150,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 11-11 Room 1 10:00~10:03 Àλ縻_ȸÀå´Ô  ¹ÚÇü¹«(´ëÇÑ»êºÎÀΰúÇÐȸ ȸÀå) 
±âŸ 11-11 Room 1 10:03~10:06 Àλ縻_ÀÌ»çÀå´Ô  ¹ÚÁß½Å(´ëÇÑ»êºÎÀΰúÇÐȸ ÀÌ»çÀå) 
±âŸ 11-11 Room 1 10:06~10:11 °ø·ÎÆÐ ¼ö¿©½Ä  ¹ÚÇü¹«(´ëÇÑ»êºÎÀΰúÇÐȸ ȸÀå) 
±âŸ 11-11 Room 1 10:11~10:15 ¸í¿¹È¸¿øÀ§Ã˽Ġ ¹ÚÁß½Å(´ëÇÑ»êºÎÀΰúÇÐȸ ÀÌ»çÀå) 
±âŸ 11-11 Room 1 10:15~10:20 AOFOG È«º¸ ¿µ»ó  () 
±³À°½Ã°£ 11-11 Room 1 10:20~10:30 (¸ðüžÆÀÇÇÐ) Metabolic dysfunction-associated fatty liver disease and subsequent development of adverse pregnancy outcomes  À̽¹Ì(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-11 Room 1 10:30~10:40 (»ý½Ä³»ºÐºñÇÐ) Risk of type 2 diabetes is increased in nonobese women with polycystic ovary syndrome: National Health Insurance Service-National Sample Cohort data  ·ù±âÁø(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 11-11 Room 1 10:40~10:50 (ºÎÀÎÁ¾¾çÇÐ) Development of rotational intraperitoneal pressurized aerosol chemotherapy to enhance drug delivery into the peritoneum  ¹Ú¼öÁø(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-11 Room 1 10:50~11:00 (ÀϹݺÎÀΰúÇÐ) Development and validation of a prediction model for bothersome stress urinary incontinence after prolapse surgery  ¿À¼ö¹Î(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 11-11 Room 1 11:00~11:20 The Red Line Initiative: women as weapons as war  Jeanne Conry(FIGO USA) 
±³À°½Ã°£ 11-11 Room 1 11:20~11:40 Fusion imaging using US and MRI: preliminary experience from the LUMIERE research platform  Laurent Salomon(Paris Descartes University France) 
±³À°½Ã°£ 11-11 Room 1 11:40~12:00 Cancer genetics for the general Gynecologist  David Cohn(The Ohio State University USA) 
±³À°½Ã°£ 11-11 Room 1 12:00~12:20 Mitochondrial replacement therapy in reproductive medicine  Shoukhrat Mitalipov(Oregon Health & Science University USA) 
Åä·Ð 11-11 Room 1 12:20~12:40 Discussion  () 
±³À°½Ã°£ 11-11 Room 1 12:40~13:10 HPV¹é½Å ÃÖ½ÅÁö°ß : Paradigm Shift & Key Data Update  ¹Î°æÁø(°í·ÁÀÇ´ë) 
È޽Ġ11-11 Room 1 13:10~13:40 Lunch  () 
±³À°½Ã°£ 11-11 Room 1 13:40~14:00 ºÐ¸¸ ÀÎÇÁ¶ó À¯Áö ±âº» ¼ö°¡ °³¼³  È²Á¾À±(°­¿øÀÇ´ë) 
±³À°½Ã°£ 11-11 Room 1 14:00~14:20 Áú°­Ã³Ä¡·á ÀûÀÀÁõ ¹× Ƚ¼öÁ¦ÇÑ °³¼± - È®ÀÎ ÇÊ¿ä  À̱âö(À̱âö ¿©¼ºÀÇ¿ø) 
Åä·Ð 11-11 Room 1 14:20~14:50 Panel Discussion  È²Á¾À± / À̱âö / Á¶¿µ´ë(°­¿øÀÇ´ë / À̱âö ¿©¼ºÀÇ¿ø / º¸°Çº¹ÁöºÎ) 
±³À°½Ã°£ 11-11 Room 2 08:00~08:15 °³¿ø°¡¿¡¼­ÀÇ º¸Çè ¼ö°¡ û±¸ ÆÁ  ±è±Ý¼®(´ÙÁ¤»êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 2 08:15~08:30 ³­ÀÓ È¯ÀÚ Áø·á ¼ö°¡ û±¸  ÁÖâ¿ì(¸¶¸®¾Æº´¿ø) 
±³À°½Ã°£ 11-11 Room 2 08:30~08:45 »ê°ú ÃÊÀ½ÆÄ Áø·á ¼ö°¡ û±¸  ¼³ÇöÁÖ(°­µ¿°æÈñ´ë) 
±³À°½Ã°£ 11-11 Room 2 08:45~09:00 ºÎÀÎ¾Ï ¹× ¼ö¼ú ½Ã Áø·á ¼ö°¡ û±¸  ÃÖÁß¼·(ÇѾçÀÇ´ë) 
±³À°½Ã°£ 11-11 Room 2 13:20~13:30 È¯ÀÚÁ᫐ ÀÇ·á±â¼ú ÃÖÀûÈ­ ¿¬±¸»ç¾÷ ¼Ò°³  Á¶¼ÛÈñ(PACEN) 
±³À°½Ã°£ 11-11 Room 2 13:30~13:40 Ãʱâ Àڱ󻸷¾Ï¿¡¼­ °¨½Ã¸²ÇÁÀýŽ»ö°ú °í½ÄÀû ¸²ÇÁÀýÀýÁ¦¼úÀÇ ºñ±³ ¿¬±¸  ±è»ó¿î(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 11-11 Room 2 13:40~13:50 ±¹³» °íÀ§Çè »ê¸ðÀÇ ÀÓ»óÀû Ư¼º ¹× ÁÖ»ê±â ¿¹ÈÄ ºÐ¼®À» ÅëÇÑ °íÀ§Çè »ê¸ð °ü¸® ¸ðµ¨ °³¹ß  ¿À¼ö¿µ(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 11-11 Room 2 13:50~14:00 Áú½ÄºÐ¸¸ ÀÓ»êºÎÀÇ »ê¿å±â °¨¿°°ú ½Å»ý¾ÆÀÇ ÁÖ»ê±â °¨¿°À» ¿¹¹æÇϱâ À§ÇÑ Áø·áÁöħ È®¸³  À̽¹Ì(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-11 Room 2 14:00~14:10 »êºÎÀΰú Àü°øÀÇ ±³À° ¼ö·Ãü°è °³¼±¹æ¾È ¿¬±¸  È«¼øö(°í·ÁÀÇ´ë) 
Åä·Ð 11-11 Room 2 14:10~14:20 ÁúÀÇÀÀ´ä  () 
È޽Ġ11-11 Room 2 14:20~14:25 Break time  () 
±³À°½Ã°£ 11-11 Room 2 14:25~14:50 »êºÎÀΰú ºÐ¾ß ȯÀÚÁ᫐ Àӻ󿬱¸ÀÇ °³¼± ¹× ¹ßÀü¹æÇâ  Á¶¼ÛÈñ±è»ó¿î¿À¼ö¿µÀ̽¹ÌÈ«¼øö(PACEN¿¬¼¼ÀǴ뼺±Õ°üÀÇ´ë¼­¿ïÀÇ´ë°í·ÁÀÇ´ë) 
È޽Ġ11-11 Room 2 14:50~15:10 Coffee Break  () 
±³À°½Ã°£ 11-11 Room 2 15:10~15:40 Èñ¼Ò¡¤±ä±ÞµµÀÔ ÇÊ¿ä ÀÇ·á±â±â °ø±Þ »ç¾÷  ÀÌÈ¿¼®(Çѱ¹ÀÇ·á±â±â¾ÈÀüÁ¤º¸¿ø °ø±Þ°ü¸®ÆÀ) 
±³À°½Ã°£ 11-11 Room 2 15:40~16:40 °¡¸íÁ¤º¸ °áÇÕÁ¦µµ ¼³¸íȸ  Á¶±Ôµ¿ ºÎ¿¬±¸À§¿ø(±¹¹Î°Ç°­º¸Çè°ø´Ü) 
±âŸ 11-11 Room 2 16:40~16:45 Àλ縻  ¹ÚÁ߽ŹæÀº¿Á(´ëÇÑ»êºÎÀΰúÇÐȸ ÀÌ»çÀåÁúº´°ü¸®Ã» °úÀå) 
±âŸ 11-11 Room 2 16:45~16:55 Á¤Ã¥¿¬±¸¿ë¿ª ¼Ò°³  Á¶±ÝÁØ ±³¼ö(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 11-11 Room 2 16:55~17:10 ÀӽźΠCOVID-19 °¨¿° ¹×¹é½ÅÁ¢Á¾  ³ª¼ºÈÆ(°­¿øÀÇ´ë) 
±³À°½Ã°£ 11-11 Room 2 17:10~17:25 ±¹³» ÀӽźΠCOVID-19 ¹é½ÅÁ¢Á¾ ÀÌ»ó¹ÝÀÀ ÇöȲ (ÀüÈ­¼³¹® °á°ú)  ¼º¿øÁØ(°æºÏÀÇ´ë) 
±³À°½Ã°£ 11-11 Room 2 17:25~17:40 ÀӽŠÁß COVID-19 ¹é½ÅÁ¢Á¾¿¡ ´ëÇÑ Àνĵµ Á¶»ç  °íÇö¼±(°¡Å縯ÀÇ´ë) 
±âŸ 11-11 Room 4 08:00~08:05 Àλ縻  ¿øÇý¼º(´ëÇÑ»êºÎÀΰúÃÊÀ½ÆÄÇÐȸ ȸÀå) 
±³À°½Ã°£ 11-11 Room 4 08:05~08:25 Å¾ÆÀÌ»ó ÀÌ¿ÜÀÇ ÃʱâÀӽŠÃÊÀ½ÆÄÀÌ»ó ¼Ò°ßÀÇ ´ëó¹ý  È²ÇѼº(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 11-11 Room 4 08:14~08:45 FNT, IT, NB, ±×¸®°í NIPT  ½ÅÀçÀº(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 11-11 Room 4 08:23~09:05 ´ÙÅÂÀӽſ¡¼­ À¶¸ð¸·¼º°ú ¾ç¸·¼ºÀÇ °áÁ¤  À̽¹Ì(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-11 Room 4 09:05~09:25 Áø´Ü °¡´ÉÇÑ ÅÂ¾Æ ±¸Á¶Àû À̻󠠼º¿øÁØ(°æºÏÀÇ´ë) 
Åä·Ð 11-11 Room 4 09:25~09:30 Discussion  () 
±³À°½Ã°£ 11-11 Room 4+5+6 15:10~15:40 Ultrasonic vs Advanced Bipolar(Feat, Voyant intelligence energy device)  ±èÈñ½Â ±³¼ö(¼­¿ï´ëº´¿ø) 
±³À°½Ã°£ 11-11 Room 4+5+6 15:40~16:00 Æó°æ ¿©¼º¿¡¼­ STEAR(Tibolone)°¡ °¡Áö´Â ÀåÁ¡  ÀÌÁö¿µ ±³¼ö(°Ç±¹´ëº´¿ø) 
±³À°½Ã°£ 11-11 Room 4+5+6 16:00~16:20 ºñÀÜ¢ç, Àڱ󻸷ÁõÀÇ »õ·Î¿î Æз¯´ÙÀÓÀÇ Á߽ɿ¡ ¼­´Ù!  ±è½½±â(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-11 Room 4+5+6 16:20~16:40 Fine details for Fetal Ultrasonographic diagnosis  ±è¿µ³² ±³¼ö(ºÎ»ê¹éº´¿ø) 
±³À°½Ã°£ 11-11 Room 4+5+6 16:40~17:00 Implementation of AI in Fetal US: present and future  ±ÇÀÚ¿µ ±³¼ö(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 11-11 Room 5 08:00~08:20 Basic performance and risk in trocar insertion  ±èÅÂÈÆ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-11 Room 5 08:20~08:40 Practical point of laparoscopic suturing and instrumentation  ±èÁ¤½Ä(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 11-11 Room 5 08:40~09:00 Which one is better? Monopolar vs. bipolar instrument  ÀÌÀÎÇÏ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 11-11 Room 5 09:00~09:20 Clinical practice in hysteroscopy  ¹Ú¼Ò¿¬(ÀÌÈ­ÀÇ´ë) 
Åä·Ð 11-11 Room 5 09:20~09:40 Discussion  () 
±âŸ 11-11 Room 6 07:55~08:00 °³È¸»ç  ÀÌÅÃÈÄ(´ëÇÑ°¡Àӷº¸Á¸ÇÐȸ ȸÀå) 
±³À°½Ã°£ 11-11 Room 6 08:00~08:20 Fertility preservation : Global view with current guidelines of international societies  ±è¼º¿ì(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-11 Room 6 08:20~08:40 Public sperm bank in Korea  ¹Ú³²Ã¶(ºÎ»êÀÇ´ë ºñ´¢±â°ú ¸í¿¹±³¼ö/Çѱ¹°ø°øÁ¤ÀÚÀºÇ࿬±¸¿ø ÀÌ»çÀå) 
±³À°½Ã°£ 11-11 Room 6 08:40~09:00 Donor oocyte bank : worldwide status and application in Korea  ÀÌ´Ù¿ë(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 11-11 Room 6 09:00~09:20 Gestational surrogacy in Korea: legal, social and ethical issues  ÀÌÀÏÇÐ(¿¬¼¼ÀÇ´ë ÀÇ·á¹ýÀ±¸®Çаú) 
Åä·Ð 11-11 Room 6 09:20~09:30 Q&A  () 
±³À°½Ã°£ 11-11 Room 7 08:00~08:10 Exposure of PM2.5 and metabolic dysfunction during pregnancy via personalized measurement of PM2.5 in South Korea: A multi-center prospective cohort, APPO (air pollution on pregnant women) study  Á¤¿¬¼º(¿¬¼¼ÀÇ´ë °­³²¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 7 08:10~08:20 Machine learning-based prediction model for spontaneous preterm birth in singleton pregnancies using midtrimester cervical elastographic parameters  Á¤À±Áö(¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 7 08:20~08:30 Melatonin restores the M1-biased macrophage to prevent preterm birth in a murine model with intrauterine inflammation  À¯³ª°æ(Â÷ÀÇ°úÇдëÇб³ °­³²Â÷º´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 7 08:30~08:40 Comparison Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) antibody levels in cord blood after vaccination with after COVID-19 infection during pregnancy  ÀÌÁö¼±(¼­¿ï´ëÇб³º´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 7 08:40~08:50 Reduction of contraction by micro-electrical stimulation of human uterine smooth muscle tissue obtained from C-section  ÃÖÀº»ù(°í·ÁÀÇ´ë ¾È¾Ïº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 7 08:50~09:00 The novel nanocarrier for treatment of preterm delivery  ±èÇý¿¬(°í·ÁÀÇ´ë ±¸·Îº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 7 09:00~09:10 Study on the relationship between Vitamin D-binding protein (VDBP) rs7041 genotype and Preterm labor  ¼­Çö°æ(°æ»ó´ëÇб³º´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 7 09:10~09:20 The Cellular and Molecular Responses to Triphenyl phosphate in Human uterine myometrium: Implications on Preterm Labor  ¿À¼Ò¶ó(µ¿¾Æ´ëÇб³º´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 7 09:20~09:30 Which placental pathologic findings affect perinatal and infant long-term outcomes of preterm-delivered intrauterine growth restriction baby?  Á¤¿µÀº(¼º±Õ°üÀÇ´ë »ï¼º¼­¿ïº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 7 09:30~09:40 Effects of Fetal Images Produced by Virtual Reality on Maternal-fetal Attachment: Randomized Clinical Trial  ½ÅÇϸ²(¼­¿ï´ëÇб³ ºÐ´çº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 7 15:10~15:20 The relationship between the success rate of External cephalic version and Breech progression angle at the outpatient clinic: a single center experience  ¼ºÁö¼ö(Áß¾Ó´ëÇб³º´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 7 15:20~15:30 Neonatal outcomes of previable preterm births according to the delivery indications  ±èÈ¿Á¤(¼­¿ï´ëÇб³ ºÐ´çº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 7 15:30~15:40 Can common carotid artery ultrasonography help in screening high-risk pregnant women?  ¹®Çý¿¬(°í·ÁÀÇ´ë ¾È»êº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 7 15:40~15:50 Risk factors for postpartum endometritis after uterine artery embolization for postpartum hemorrhage  ÀÌÀºÁø(¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 7 15:50~16:00 ÀӽŠ½Ã±â¿¡ µû¸¥ Àӽżº ´ç´¢ ¿¹Ãø ¸ðµ¨  À̼±ÀÇ(°¡Å縯ÀÇ´ë ¼­¿ï¼º¸ðº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 7 16:00~16:10 Distribution of phthalates in pregnant women-matching biological father pairs and thyroid hormone concentrations in cord sera  ÀÌÇöÁö(ÀÎÁ¦ÀÇ´ë ÀÏ»ê¹éº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 7 16:10~16:20 Serum vitamin D can be used as biomarkers in pregnancy indused hypertension?  °­¹ÎÁö(°æ»ó´ëÇб³º´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 7 16:20~16:30 Machine learning approach for the prediction of dystocia  ÀÌÇѳª(Â÷ÀÇ°úÇдëÇб³ ºÐ´çÂ÷º´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 7 16:30~16:40 The umbilical cord blood microRNA profiles in spontaneous preterm birth and term birth  Æí½Â¿¬(°­µ¿°æÈñ´ëÇб³º´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 7 16:40~16:50 The effect of maternal body mass index on 100gm oral glucose tolerance test profile in gestational diabetes mellitus with singleton and twin pregnancies  ÀÌÀ¯¹Î(¼º±Õ°üÀÇ´ë »ï¼º¼­¿ïº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 7 16:50~17:00 Effect of hypoxemia on Preterm birth and Small for gestational age in SARS CoV-2 infection during singleton pregnancy In South Korea  ±èÀÇÇõ(±¹¹Î°Ç°­º¸Çè°ø´Ü Àϻ꺴¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 7 17:00~17:10 Maternal risk factors for recurrent small-for-gestational age at term neonates in South Korea  Á¶ÀºÇý(ÀÎÁ¦ÀÇ´ë ºÎ»ê¹éº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 7 17:10~17:20 A comparison of anxiety and depression in postpartum women  ±èº¸¶÷(Á¦ÁÖ´ëÇб³º´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 7 17:20~17:30 The relationship between maternal factors and neonatal factors in an unsuccessful vaginal delivery  ¹Ú¼ÒÇö(Â÷ÀÇ°úÇдëÇб³ ºÐ´çÂ÷º´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 8 08:00~08:10 Serially collected circulating tumor DNA (ctDNA) in BRCA mutated ovarian patients receiving PARP inhibitor: implication for resistance mechanism and post-progression therapy  ±èÀ¯³ª(¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 8 08:10~08:20 The Impact of Postoperative Residual Disease in Patients with Primary Epithelial Ovarian Cancer: A Systematic Review and Meta-Analysis in the Era of Targeted therapy era  ±èÁöÇö(±¹¸³¾Ï¼¾ÅÍ) 
±³À°½Ã°£ 11-11 Room 8 08:20~08:30 The impact of enhanced recovery after surgery (ERAS) on perioperative and oncological outcomes in ovarian cancer surgery  ÇÏÈñÀº(¼º±Õ°üÀÇ´ë »ï¼º¼­¿ïº´¿ø »êºÎÀΰúr) 
±³À°½Ã°£ 11-11 Room 8 08:30~08:40 Effect of subcutaneous drain on wound dehiscence and infection in midline laparotomy for gynecological disease (KGOG 4001)  ±è³²°æ(¼­¿ï´ëÇб³ ºÐ´çº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 8 08:40~08:50 BRCA µ¹¿¬º¯ÀÌ°¡ ÀÖ´Â ³­¼Ò¾Ï ȯÀÚÀÇ À¯¹æ¾Ï À§Çè: Meta-analysis  ±è¼­¿¬(Â÷ÀÇ°úÇдëÇб³ ºÐ´çÂ÷º´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 8 08:50~09:00 IMMUNE CHARACTERISTICS OF TUMOR-INFILTRATING T CELLS IN OVARIAN CLEAR CELL CARCINOMA RELATIVE TO OVARIAN HIGH-GRADE SEROUS CARCINOMA  ¹ÚÁؽÄ(¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 8 09:00~09:10 Impact of COVID-19 pandemic on Cervical cancer screening - Comparison between healthy women and disabled population; A nationwide study in Republic of Korea  Á¤¼ÒÇö(°í·ÁÀÇ´ë ±¸·Îº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 8 09:10~09:20 Marked impact of preeclampsia on cancer risk: A Nationwide Population-Based Cohort Study  ¾î°æÁø(¿¬¼¼ÀÇ´ë ¿ëÀμ¼ºê¶õ½ºº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 8 09:20~09:30 Endometrial surveillance strategy for detection of tamoxifen-related uterine cancers  ¹èÇöÁö(¾ÆÁÖ´ëÇб³º´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 8 09:30~09:40 Expression and significance of Caveolin-1(Can-1) in Ovarian clear cell carcinoma(OCCC)  Á¤ÇÏÀº(ºÎ»ê´ëÇб³º´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 8 15:10~15:20 Risk factor for the failure of first-line PARP inhibitor maintenance therapy in patients with advanced ovarian cancer: a single- center retrospective study  Á¤´ÙÀº(¼­¿ï´ëÇб³ ºÐ´çº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 8 15:20~15:30 Bromodomain inhibitor induces cell cycle arrest and apoptotic cell death in epithelial ovarian cancer  ±è¿©·¡(¼­¿ï´ëÇб³ ºÐ´çº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 8 15:30~15:40 Discrepancy between preoperative tumor marker and imaging outcomes for the predicting ovarian malignancy  ±è¼ÒÈñ(ºÎ»ê´ëÇб³º´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 8 15:40~15:50 Dyslipidemia is Positively Associated with Cervical Cancer in Korea: Korean National Health and Nutrition Examination Survey 2010–2020  À̼±¹Ì(°í·ÁÀÇ´ë ¾È¾Ïº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 8 15:50~16:00 Prediction for Platinum Resistance of Chemotherapy in Epithelial Ovarian Cancer patients based on Magnetic Resonance Images.  ¼ÛÈñ°æ(°¡Å縯ÀÇ´ë ÀÎõ¼º¸ðº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 8 16:00~16:10 Treatment outcomes and complications in FIGO stage IIIC and IVB endometrioid endometrial cancer patients presenting as nodal spreads following systematic lymphadenectomy and adjuvant therapy  µ¿¼ö·Ã(¾ÆÁÖ´ëÇб³º´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 8 16:10~16:20 Genomic alteration before and after progression on first exposure to PARP inhibitor (PARPi) among ovarian cancer patients undergoing PARPi re-treatment  À̰渲(¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 8 16:20~16:30 Role of Klotho and N-acetylcysteine in Oxidative stress associated with the Vitrification of Ovarian tissue  À̼±¹Ì(°í·ÁÀÇ´ë ¾È¾Ïº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 8 16:30~16:40 Transcriptomic Immune Profiles Can Represent the Tumor Immune Microenvironment Related to the Tumor Budding Histology in Uterine Cervical Cancer  Á¤°æÈÆ(Ä¥°î°æºÏ´ëÇб³º´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 8 16:40~16:50 Histopathological evaluation of cervical excision specimen according to age in CIN2 patients  ÇöÁ¤¾Æ(°Ç±¹´ëÇб³º´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 8 16:50~17:00 Laparo-Endoscopic Single-Site versus Conventional Laparoscopic Surgery for Early-Stage Endometrial Cancer; Prospective Randomized Controlled Trial (LESS-E)  °­¿ÁÁÖ(¿ï»êÀÇ´ë ¼­¿ï¾Æ»êº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 8 17:00~17:10 Pre-treatment neutrophil-to-lymphocyte ratio is associated with improved overall survival in patients with gynecological cancer treated with immunotherapy  È«ÁØ¿µ(¼º±Õ°üÀÇ´ë »ï¼º¼­¿ïº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 8 17:10~17:20 Clinical implication of P16 immunostaining for prediction of prognosis in young women with moderate cervical dysplasia.  À̽¹Ì(°è¸íÀÇ´ë µ¿»êÀÇ·á¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 8 17:20~17:30 Adverse Effects on Overall Survival of Duration of Antibiotics Use Prior to Immune Checkpoint Inhibitors in Patients with Recurrent Gynecologic Malignancies  Á¤ÇýÁö(¼º±Õ°üÀÇ´ë »ï¼º¼­¿ïº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 9 08:00~08:10 Microorganisms in human follicular fluid in Endometriosis and Non-endometriosis women  ¼ÛÁö¼ö(°¡ÃµÀÇ´ë ±æº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 9 08:10~08:20 Fallopian tube as a possible modulator associated in the development of endometriosis  ¹ÚÇý¹Î(¿¬¼¼ÀÇ´ë °­³²¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 9 08:20~08:30 Development of adeno-associated virus(AAV)-mediated shRNA delivery as a novel gene therapy for endometriosis  ÀÌÀç°æ(¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 9 08:30~08:40 Estradiol treatment increases M2-like visceral adipose tissue macrophages in obese ovariectomized mice regardless of its anorectic action  ³²½ÂÇö(°í·ÁÀÇ´ë ¾È¾Ïº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 9 08:40~08:50 Digital spatial profiling of endometriosis-derived clear cell and endometrioid carcinomas  ¹Ú¿µÈÆ(¿¬¼¼ÀÇ´ë °­³²¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 9 08:50~09:00 Particulate matter(PM) exposures induce adverse effects on endometrium via aberrant apoptotic pathways in vitro and in vivo.  Ãß¼ºÇÊ(¿¬¼¼ÀÇ´ë °­³²¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 9 09:00~09:10 Follicular environmental change via HMGB-1 and TLR4 in endometriosis  ±èÇýÀÎ(¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 9 09:10~09:20 Vitamin D Status and Bone Health in Postmenopausal Women Working in Greenhouses  Á¶ÀçÀ±(°æ»ó´ëÇб³º´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 9 09:20~09:30 ¸ð¹ÙÀÏ ¾Û ÀڷḦ ÀÌ¿ëÇÏ¿© ºÐ¼®ÇÑ Äڷγª-19 ¿¹¹æÁ¢Á¾°ú ÀÌ»ó ÀÚ±ÃÃâÇ÷ÀÇ °ü°è  ±è¼ºÀº(¼º±Õ°üÀÇ´ë »ï¼º¼­¿ïº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 9 09:30~09:40 THE EFFECT OF CATHETER-DIRECTED ETHANOL SCLEROTHERAPY ON OVARIAN RESERVE IN PATIENTS WITH RECURRENT ENDOMETRIOSIS: COMPARATIVE ANALYSIS WITH PRIMARY ENDOMETRIOSIS  ÀÌ¿©Áø(¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 9 15:10~15:20 Relationship between hematologic parameters related to systemic inflammation and insulin resistance in women with polycystic ovary syndrome  Á¶¹Î°æ(ÀÎÁ¦ÀÇ´ë ÇØ¿î´ë¹éº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 9 15:20~15:30 Leptin Stimulates Endometriosis Development in Obesity  ¹è³ª¿µ(°í·ÁÀÇ´ë ±¸·Îº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 9 15:30~15:40 Determine the impact of different types of SARS-Cov-2 vaccines on IVF outcome  ½Å¼Ò¿¬(Â÷ÀÇ°úÇдëÇб³ ºÐ´çÂ÷º´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 9 15:40~15:50 Á¶»ê±â¿Õ·ÂÀÌ ¾ø´Â ¹«Áõ»ó ¿©¼º¿¡¼­ Á¶»ê ¿¹ÃøÀ» À§ÇÑ ÀڱðæºÎ ±æÀÌ ÃøÁ¤ÀÇ ÀûÀýÇÑ ½Ã±â  ±è¼¼Áø(°¡Å縯ÀÇ´ë ¼­¿ï¼º¸ðº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 9 15:50~16:00 Effect of pelvic artery embolization on AMH level in postpartum hemorrhage patients  Çö¼ö¹Î(¼­¿ï´ëÇб³ ºÐ´çº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 9 16:00~16:10 Obstetric factors associated with non-cephalic presentation in late pregnancy  ½ÅÀ¯¹Ì(¼­¿ï´ëÇб³ ºÐ´çº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 9 16:10~16:20 The Outcome of Vacuum Assisted Delivery (VAD) : 2007-2022 Experiences in a Single Institution  ¹Ú¼ÒÀ±(ÇѸ²ÀÇ´ë °­³²¼º½Éº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 9 16:20~16:30 Pregnancy outcomes and obstetrical complications of twin pregnancies with endometriosis: A single center cohort study  ÃÖÁö¿¬(Â÷ÀÇ°úÇдëÇб³ °­³²Â÷º´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 9 16:30~16:40 The effect of continuous bupivacaine subfascial wound infusion after cesarean delivery  ÀÌÁ¤À±(¼­¿ï´ëÇб³ ºÐ´çº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 9 16:40~16:50 Threshold of 50g screening test for gestational diabetes mellitus in twin pregnancy-should it be the same as singleton?  ±èÈ¿½Å(Ä¥°î°æºÏ´ëÇб³º´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 9 16:50~17:00 ÀÓ½ÅÇÕº´ÁõÀÇ ¿¹Ãø ÀÎÀڷμ­ÀÇ Ç㸮 µÑ·¹  ±è´Ù¿µ(¼­¿ï´ëÇб³º´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 9 17:00~17:10 The Outcome of Repeat Cerclage in Women with Prolapsed Membrane following Prior Cerclage  Å¹ÇöÁø(ÇѸ²ÀÇ´ë °­³²¼º½Éº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 9 17:10~17:20 Àڱ󻸷Áõ°ú ÀÓ½ÅÇÕº´ÁõÀÇ »ó°ü°ü°è: °Ç°­º¸Çè½É»çÆò°¡¿ø ºòµ¥ÀÌÅÍ ºÐ¼® ¿¬±¸  ¼Û¸íÀº(¼­¿ïƯº°½Ã º¸¶ó¸Åº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 9 17:20~17:30 ÀüÄ¡ÅÂ¹Ý ÀӽźÎÀÇ Å¹ÝÀ§Ä¡¿¡ µû¸¥ Ãâ»ê ÀüÈÄ ÇÕº´ÁõÀÇ ºñ±³  ¾È¼±¾Æ(°¡ÃµÀÇ´ë ±æº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 10 08:00~08:10 Development and validation of a prediction model for postoperative urinary retention after prolapse surgery  ±è¹ÎÁÖ(¼­¿ï´ëÇб³º´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 10 08:10~08:20 Diagnostic accuracy of retrograde voiding trial for predicting spontaneous voiding function after prolapse and urinary incontinence surgery  °í³ªÇö(¼­¿ï´ëÇб³º´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 10 08:20~08:30 USP10 modulates estrogen receptor in Uterine Adenomyosis  °ûÀ翵(À»ÁöÀÇ´ë À»Áöº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 10 08:30~08:40 External validation of de novo stress urinary incontinence prediction model after pelvic organ prolapse surgery in Korean women  ÀÌÀ¯Á¤(¼­¿ï´ëÇб³º´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 10 08:40~08:50 Lactobacillus probiotics improves dysbiotic vaginal microbiota through gut-vagina-axis in Korean women  ¹Ú¼±È­(ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐºÎ¼Ó ¸ñµ¿º´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 10 08:50~09:00 Endometrium assessment in breast cancer patients with tamoxifen – comparing results from conventional ultrasonography and elastosonography  Á¶Çöºó(ºÎ»ê´ëÇб³º´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 10 09:00~09:10 The Effect of New Diagnosis-Related Group Payment System on Quality Care and Health Care Cost in the Field of Obstetrics and Gynecology In Korea  Á¤¿¬¼ö(±¹¹Î°Ç°­º¸Çè°ø´Ü Àϻ꺴¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 10 09:10~09:20 ±â°èÇнÀ(Machine Learning)À» ÀÌ¿ëÇÑ ¿þ¾î·¯ºí µð¹ÙÀ̽ºÀÇ »ýü½ÅÈ£¿Í ¿ù°æ°ü·Ã Áõ»ó¿¡ µû¸¥ ¿ù°æÁֱ⠿¹Ãø  ¹Ú¼±È­(¿¬¼¼´ëÇб³ ¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 10 09:20~09:30 Initial experience of Single-port laparoscopic hysterectomy using ArtiSential¢ç wristed articulated needle holder for vaginal vault suture  ±è´Ù¿µ(¼­¿ï´ëÇб³º´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 10 09:30~09:40 Postoperative outcomes of ovarian-preserving surgery in premenopausal women with adnexal torsion  ÃÖÀº¾Æ(¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 10 15:10~15:20 »ý¸®¾ç °ú´Ù¸¦ Æò°¡ÇÏ´Â °´°üÀûÁöÇ¥·Î¼­ÀÇ »ý¸®´ëÀÇ Ç÷¾×µ¢¾î¸® À¯¹«ÀÇ Á߿伺.  Á¤À±¿µ(´ë±¸°¡Å縯´ëÇб³º´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 10 15:20~15:30 Continuation of management of ureteral injury after gynecologic surgery – Experience from a tertiary-care institute  ¿À¼öÇö(°¡ÃµÀÇ´ë ±æº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 10 15:30~15:40 Visceral obesity as a risk factor of incisional hernia after single-port laparoscopic gynecologic surgery  ±èÁö¾Ö(°¡Å縯ÀÇ´ë ´ëÀü¼º¸ðº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 10 15:40~15:50 Most uterine fibroids significantly decrease in size spontaneously after delivery  È«ÁØ¿µ(¼º±Õ°üÀÇ´ë »ï¼º¼­¿ïº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 10 15:50~16:00 The use of mechanical bowel enema in robotic assisted laparoscopic surgery in gynecology  ¹®Áö¼ö(°¡Å縯ÀÇ´ë ÀºÆò¼º¸ðº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 10 16:00~16:10 Risk factor and incidence of occult malignancy in patients receiving vaginal hysterectomy for pelvic organ prolapse  Á¶Á¤¼ö(¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 10 16:10~16:20 A retrospective single-center analysis of the 1000 gynecologic robotic-assisted laparoscopic surgery cases  ¹ÎÀ±Á¤(°Ç±¹´ëÇб³º´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 10 16:20~16:30 Predictive factors of Oophorectomy for Adnexal torsion based on clinical and Pathological characteristics: A Single Center Retrospective Study  ±è½ÂÈ£(ÇѸ²ÀÇ´ë µ¿Åº¼º½Éº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 10 16:30~16:40 Association osteoporosis and hysterectomy with ovarian preservation: National Health Insurance Database  Á¤Èñ¿µ(ÀÎÁ¦ÀÇ´ë »ó°è¹éº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 10 16:40~16:50 Clinical feature of ectopic pregnancy with massive hemorrhage  ¹éÁöÇý(°Ç±¹´ëÇб³º´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 10 16:50~17:00 CONSERVATIVE SURGERY FOR DIFFUSE UTERINE LEIOMYOMATOSIS: EXPERIENCE OF 16 CASES OF RADICAL MYOMECTOMY IN A SINGLE CERNTER.  ±Ç¼ÒÁ¤(À»Áö´ëÇб³º´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 10 17:00~17:10 Prognostic significance of histological grade in low-risk endometrial cancer  ±è»óÀÏ(°¡Å縯ÀÇ´ë ¼ººó¼¾Æ®º´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 10 17:10~17:20 The efficacy and adverse effects of PARP inhibitor in the treatment of ovarian cancer patient  ÃÖº¸¶÷(°¡Å縯ÀÇ´ë ¼­¿ï¼º¸ðº´¿ø »êºÎÀΰú) 
±³À°½Ã°£ 11-11 Room 10 17:20~17:30 Comparison of Surgical outcomes between Single-port laparoscopic operation and da Vinci single port robotic operation  ±èÁ¤¹Î(°í·ÁÀÇ´ë ¾È¾Ïº´¿ø »êºÎÀΰú) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦108Â÷ ´ëÇÑ»êºÎÀΰúÇÐȸ Çмú´ëȸ(1ÀÏÂ÷) : 2022-11-11""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ¿ï»êÁß¾Óº´¿ø ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ ¿ï»êÁöȸ ¿¬¼ö°­Á : 2022-11-11
´ÙÀ½±Û ´ëÇѼ¼Æ÷º´¸®ÇÐȸ 2022³â 11¿ù ½½¶óÀ̵弼¹Ì³ª : 2022-11-11
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21135 °æ±â Á¦10Â÷ ¿¬¼¼ÀÇ´ë ¼Ò¾Æû¼Ò³â°ú Áö¿ªÀÇ»ç Áý´ãȸ : 2024-07-31 0 25 2024-06-19
21134 °æ±â 2024 Çѱ¹¼ö¸éÇÐȸ ÇÏ°èÇмú´ëȸ : 2024-07-26 0 45 2024-06-19
21133 ¼­¿ï 2024³â ´ëÇÑÇǺη¹ÀÌÀúÇÐȸ Á¦25ȸ Çмú´ëȸ : 2024-07-21 0 31 2024-06-19
21132 ¼­¿ï ´ëÇÑÀÓ»ó¾Ï´ë»çÀÇÇÐȸ 2024³â Ãß°èÇмú´ëȸ IVC¿Í Detox : 2024-07-21 0 24 2024-06-19
21131 ´ë±¸ ´ë±¸°æºÏ³»°úÇÐȸ 2024³â Á¤±âÇмú´ëȸ : 2024-07-21 0 24 2024-06-19
21130 Á¦ÁÖ Á¦13ȸ ´ëÇѳ»ºÐºñÇÐȸ Á¦ÁÖÁöȸ ¿¬¼ö°­Á : 2024-07-20 0 12 2024-06-19
21129 ±¤ÁÖ Á¦225Â÷ ´ëÇÑ¿µ»óÀÇÇÐȸ ±¤ÁÖÀü³²Áöȸ ¿¬¼ö°­Á : 2024-07-16 0 14 2024-06-19
21128 ºÎ»ê ´ëÇѳ»°úÀÇ»çȸ Á¦3ȸ ÃÊÀ½ÆÄ ½ÇÀü ¾ÆÄ«µ¥¹Ì : 2024-07-15 0 26 2024-06-19
21127 ¼­¿ï 2024 ¼¼ºê¶õ½ºº´¿ø ¼ÒÈ­±âÇÐ ¿¬¼ö°­Á : 2024-07-14 0 26 2024-06-19
21126 ¼­¿ï (¿Â¶óÀÎ) 2024³â ´ëÇÑôÃß¿µ»óÀÇÇÐȸ Á¤±â¿¬¼ö°­Á : 2024-07-14 0 15 2024-06-19
21125 ¼­¿ï Á¦29Â÷ Ưº°¿¬¼ö°­Á – »êºÎÀΰú Áúȯ óġÀÇ ÃֽŠÁö°ß : 2024-07-14 0 21 2024-06-19
21124 °­¿ø 2024³â ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ °­¿øÁöȸ ¿¬¼ö°­Á : 2024-07-14 0 18 2024-06-19
21123 ¼­¿ï 2024³â ´ëÇѹ̼¼¼ö¼úÇÐȸ Ãá°è ¹Ì¼¼¼ö¼ú ¿öÅ©¼ó : 2024-07-14 0 19 2024-06-19
21122 ¼­¿ï Çѱ¹¹é³»Àå±¼Àý¼ö¼úÇÐȸ 2024 KSCRS Annual Symposium(2ÀÏÂ÷) : 2024-07-14 0 12 2024-06-19
21121 ¼­¿ï Á¦8ȸ ÀüÀÓÀÇ Àü°øÀÇ °³¿øÀǸ¦ À§ÇÑ °£Áúȯ ¿¬¼ö°­Á : 2024-07-14 0 21 2024-06-19
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷